Quality-of-Life Assessment in Patients With Ovarian Cancer

The Treatment Preferences of Women Diagnosed With Ovarian Cancer

NCT03367260 ·Status: COMPLETED

Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172

NCT00477867 ·Status: WITHDRAWN ·Phase: NA

Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer

NCT02082470 ·Status: COMPLETED ·Phase: NA

Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

NCT01080521 ·Status: COMPLETED

Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their Caregivers

NCT02412124 ·Status: TERMINATED ·Phase: NA

Women Surviving Ovarian Cancer

NCT00596349 ·Status: COMPLETED

Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial Cancer

NCT00004909 ·Status: COMPLETED

DOD Long-Term Survivors of Ovarian Cancer

NCT02321735 ·Status: UNKNOWN ·Phase: NA

Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

NCT01366183 ·Status: UNKNOWN

Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer

NCT03466788 ·Status: COMPLETED ·Phase: NA

Long Term Survivors in Ovarian Cancer

NCT03128294 ·Status: TERMINATED

Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTO

NCT06917469 ·Status: COMPLETED

Chemotherapy-Related Toxicities In Ovarian Cancer Patients

NCT00508378 ·Status: COMPLETED

Study of Predictive Factors of Chemoresistance in Ovarian Cancer

NCT02878122 ·Status: COMPLETED

Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy

NCT03418844 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Survival Data and Characteristics of Finisterian Patients Treated With PARP Inhibitors for Ovarian Cancer Between 2014 and 2019.

NCT04573933 ·Status: COMPLETED

QoL-Comparison Between Trabectedin/PLD and Pt-based Therapy in Patients With Pt-sensitive Recurrent Ovarian Cancer

NCT03164980 ·Status: TERMINATED ·Phase: PHASE4

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT00719303 ·Status: UNKNOWN ·Phase: PHASE3

Appraising Medical Trial Experiences of Ovarian Cancer Patients

NCT05801796 ·Status: NOT_YET_RECRUITING

Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer

NCT00003998 ·Status: COMPLETED ·Phase: PHASE3

A Real-World Patient-Reported Outcomes Study in Patients With Long-Term Use of Niraparib

NCT06037213 ·Status: UNKNOWN

Individualized Health Management of Epithelial Ovarian Cancer: A Retrospective Study

NCT06085456 ·Status: RECRUITING

Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT00958698 ·Status: UNKNOWN ·Phase: NA

Ovarian Cancer Radiomics Approach in CT Led Evaluation

NCT06817174 ·Status: RECRUITING

Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer

NCT00660842 ·Status: UNKNOWN ·Phase: PHASE3